Ongoing studies are also assessing the advantage of combined therapy of BRD4 inhibitors and Stat3 blockers or BRD4 inhibitors with chemotherapy over monotherapy in suppressing cancer growth (Ramadoss and Mahadevan, 2018; Duan et al., 2023). The gene discussed is STAT3; the disease is cancer.